A lung infection registry study in Austria
Part of Infections clinical trials.
This study creates a registry of patients in Austria who have a lung infection caused by tuberculosis or similar bacteria. By joining, you help researchers learn more about these infections and how to better treat them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung infection caused by tuberculosis or a similar bacteria (NTM).
- You are 18 years old or older.
- You can understand what the study involves and agree to join.
- You live in Austria or are being treated in Austria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a real-world record of people in Korea with a lung infection caused by specific non-tuberculous mycobacteria (not tuberculosis). It may help researchers better understand these infections and treatment patterns by tracking patients as they start new therapy.
This study is a registry that collects information from adults with tuberculosis in Europe. It helps researchers better understand the disease and improve care.
This study will build a Canadian registry for people with bronchiectasis (not from cystic fibrosis) and NTM infections. The goal is to track health outcomes over time to improve care.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
This study looks at how the immune system and natural germs in the lungs work in people who have recently been in close contact with someone with active tuberculosis (TB). It aims to better understand how the body responds to TB exposure.
This study collects information from people with interstitial lung disease in Austria to learn more about the condition and how it progresses. It does not involve any experimental treatment.
Hear when a new Non-Tuberculous Mycobacterial Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.